Delivery Order SPE2DB20D3101-SPE2DB26FQTR8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,719.96 to AmerisourceBergen Drug Corp for the supply of Solu-Medrol 125 mg vials. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of October 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same city. This delivery order represents a task...
- The Defense Logistics Agency awarded a delivery order valued at $2,017.32 to AmerisourceBergen Drug Corp for the supply of Solu-Medrol 125 mg vials. This firm fixed-price delivery order, awarded on October 27, 2025, was issued without a set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by October 28, 2025, with fulfillment performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Solu-Medrol 40 mg vials valued at $5,223.67 with a firm fixed price structure. The contract, with an ultimate completion date of August 8, 2025, represents a competitively awarded, non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,292.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Solu-Medrol 125mg in quantities of 25 units. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of July 16, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs...
- The Defense Logistics Agency awarded a delivery order valued at $6,127.81 to AmerisourceBergen Drug Corp for the supply of Solu-Medrol 125 mg vials. This firm fixed price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 14, 2025. The award fulfills pharmaceutical supply requirements with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,249.00 to AmerisourceBergen Drug Corp for the supply of Solu-Medrol 125 mg vials. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure with an ultimate completion date of November 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a small-value...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of SOLU-MEDROL 2,000 mg vials. This non-set-aside, firm fixed-price delivery order has a ceiling value of $1,002.48 and an ultimate completion date of July 14, 2025. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,083.44 to AmerisourceBergen Drug Corp for the supply of Solu-Medrol 125 mg vials. This non-competitive, firm fixed-price delivery order was awarded on October 30, 2025, with an ultimate completion date of October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Solu-Medrol (methylprednisolone sodium succinate) is a corticosteroid used in military and federal healthcare...
- The Defense Logistics Agency (DLA) awarded a $1,131.01 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,691,153 SOLU-MEDROL 125 mg vials. This order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for SOLU-MEDROL 1 gram vials valued at $3,330.42. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery order is issued under...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB26FQTR8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Solu-Medrol 125 mg vials, valued at $1,531.56. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 13, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contractor's established track record of delivering diverse pharmaceutical products—including specialty medications, vaccines, and medical supplies across multiple therapeutic domains—demonstrates its capability to meet federal medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/12/25 |